Found 8 matching trials
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants
PHASE2The purpose of this study is to learn about the safety of a new pneumococca...
Status
Active Not Recruiting
Location
Northwest Arkansas Pediatric Clinic
Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED)
PHASE3This is a study of V114 in children infected with HIV. Participants will be...
Location
Perinatal HIV Research Unit ( Site 0042)
Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)
PHASE3The primary objectives of this study are to evaluate the safety and tolerab...
Location
Aventiv Research ( Site 0022)
Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV) (V116-007, STRIDE-7)
PHASE3This study will evaluate the safety, tolerability, and immunogenicity of a ...
Location
Pueblo Family Physicians ( Site 0014)
Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age
PHASE1The purpose of the study is to describe the safety and immunogenicity of Pn...
Location
Orange County Research Center
Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15
PHASE4Streptococcus pneumoniae (pneumococcus) is a bacterium that causes just und...
Location
Liverpool Vaccine Group
MISP 60528 Pneumococcal Vaccination
N/AThis study aims to use two different blood tests (ELISA and OPA) to study r...
Location
Montefiore Medical Center, Infectious Diseases
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)
PHASE3This a study of V116 in adults ≥50 years of age who previously received a p...
Location
Central Research Associates ( Site 0024)